LH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen.

Abstract

This study was initiated to evaluate the efficacy of luteinizing hormone-releasing hormone (LH-RH) agonists in protecting premenopausal patients against the adverse gynaecological effects induced by tamoxifen. Between January 1998 and January 2000, 85 premenopausal breast cancer patients were included in this prospective study. All were to receive LH-RH… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.